Comparison of telemetry and high-definition oscillometry for blood pressure measurements in conscious dogs: effects of torcetrapib.
This study compared torcetrapib-induced blood pressure (BP) changes simultaneously obtained by high-definition oscillometry (HDO) and telemetry. Male beagles (n = 6) received single oral doses of vehicle or torcetrapib at 10 or 30 mg/kg; BP were acquired simultaneously by HDO and telemetry from 2 h before dosage until 7 h afterward. Systolic, diastolic, and mean arterial pressures (MAP) and heart rate were compared by using Altman-Bland agreement analysis. Dogs were allocated into subgroups according to temperament and baseline MAP (less than 110 mm Hg and 110 mm Hg or greater). Both methods demonstrated high precision. HDO recordings exhibited higher variability for all parameters (inclusive MAP SDs were 7.0 +/- 2.7 mm Hg for HDO compared with 3.4 +/- 1.9 mm Hg for telemetry), accompanied by a positive bias for all pressures (systolic, 10.4 mm Hg; diastolic, 5.7 mm Hg; MAP, 1.9 mm Hg). Both methods detected similar maximal increases in MAP with 30 mg/kg torcetrapib (HDO, 15.8 +/- 10.4 mm Hg; telemetry, 15.8 +/- 5.3 mm Hg). No significant effects were noted for heart rate. Torcetrapib elicited a dose-dependent increase in BP in dogs with baseline MAP of less than 110 mm Hg, whereas increases were maximal with 10 mg/kg in the other group, and dose-dependence was no longer observed. BP changes were influenced by animal temperament, demonstrating that HDO results must be interpreted with caution. HDO may provide a useful and accurate method for noninvasive BP measurements in canine studies.
Meyer
Olivier
O
F Hoffmann-La Roche, Pharmaceuticals Division Non-Clinical Drug Safety, Basel, Switzerland.
Jenni
Roland
R
Greiter-Wilke
Andrea
A
Breidenbach
Alexander
A
Holzgrefe
Henry H
HH
D000818:Animals; D001522:Behavior, Animal; D001794:Blood Pressure / Q000187:drug effects*; D001795:Blood Pressure Determination / Q000379:methods / Q000662:veterinary*; D004285:Dogs / Q000502:physiology*; D006339:Heart Rate / Q000187:drug effects; D009991:Oscillometry / Q000379:methods / Q000662:veterinary*; D011804:Quinolines / Q000494:pharmacology*; D015203:Reproducibility of Results; D013686:Telemetry / Q000379:methods / Q000662:veterinary*
D011804:Quinolines; C483909:torcetrapib
J Biopharm Stat. 2007;17(4):571-82
17613642
Hypertension. 2008 Jan;51(1):112-8
17998476
J Appl Physiol (1985). 1996 Aug;81(2):1012-8
8872674
Can J Vet Res. 2006 Jul;70(3):211-7
16850944
J Am Vet Med Assoc. 2002 Sep 1;221(5):646-50
12216901
Biomed Instrum Technol. 1999 Sep-Oct;33(5):427-30
10511912
Curr Pharm Des. 2009;15(3):272-89
19149618
J Vet Intern Med. 2007 May-Jun;21(3):542-58
17552466
Vet Anaesth Analg. 2004 Jan;31(1):27-39
14756751
Br J Pharmacol. 2008 Aug;154(7):1465-73
18536749
Fed Regist. 2005 Oct 20;70(202):61133-4
16237859
J Pharmacol Toxicol Methods. 2009 Jan-Feb;59(1):35-8
18983927
J Cardiovasc Pharmacol. 2009 Dec;54(6):543-51
19770671
J Appl Physiol. 1960 Mar;15:323-4
14434949
Int J Pharm. 2008 Mar 3;351(1-2):15-22
18024021
Endocrinology. 2009 May;150(5):2211-9
19164467
Ned Tijdschr Geneeskd. 2008 May 10;152(19):1088-90
18552062
Neth J Med. 2008 Dec;66(11):480-2
19075314
Res Vet Sci. 1996 Jul;61(1):17-21
8819188
Vet Res Commun. 2010 Mar;34(3):217-27
20306347
J Physiol. 2000 May 15;525 Pt 1:263-70
10811742
Proc Soc Exp Biol Med. 1979 Jul;161(3):266-9
88738
Am J Vet Res. 2006 Sep;67(9):1541-5
16948598
Can J Vet Res. 1995 Jul;59(3):238-40
8521360